Source:http://linkedlifedata.com/resource/pubmed/id/16966255
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2006-9-12
|
pubmed:abstractText |
The chemokine receptor CCR6 is expressed by CD4+ T cell effector/memory and regulatory effector/memory (TREM) subsets. Here we show that CCR6 modulates graft-versus-host-disease (GVHD) responses in both alloreactive CD4+ T effector cells and regulatory T (Treg) cells. Mortality and morbidity due to acute GVHD were drastically reduced and delayed when naïve T cells were derived from CCR6-deficient donor mice. This deficiency also affected the suppressive ability of Treg cells in GVHD. CCR6-/- Treg cells were able to suppress T cell proliferation in vitro, but their in vivo capacity to downregulate target tissue damage induced by naïve wild type (WT) T cells was impaired. The data demonstrate a requirement for CCR6 in CD4+ T cell function in GVHD, in both effector and regulatory cell subsets.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
47
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1469-76
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16966255-Acute Disease,
pubmed-meshheading:16966255-Animals,
pubmed-meshheading:16966255-CD4-Positive T-Lymphocytes,
pubmed-meshheading:16966255-Cell Proliferation,
pubmed-meshheading:16966255-Graft vs Host Disease,
pubmed-meshheading:16966255-Immunity,
pubmed-meshheading:16966255-Mice,
pubmed-meshheading:16966255-Mice, Knockout,
pubmed-meshheading:16966255-Receptors, CCR6,
pubmed-meshheading:16966255-Receptors, Chemokine,
pubmed-meshheading:16966255-T-Lymphocytes, Regulatory
|
pubmed:year |
2006
|
pubmed:articleTitle |
CCR6 regulates the function of alloreactive and regulatory CD4+ T cells during acute graft-versus-host disease.
|
pubmed:affiliation |
Departamento de Inmunología y Oncología, Centro Nacional de Biotecnología/CSIC, Darwin 3, Universidad Autónoma de Madrid, Cantoblanco, E-28049, Madrid, Spain.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|